X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10710) 10710
Publication (488) 488
Newsletter (174) 174
Book Chapter (100) 100
Book Review (44) 44
Conference Proceeding (16) 16
Government Document (14) 14
Dissertation (12) 12
Magazine Article (5) 5
Newspaper Article (5) 5
Book / eBook (3) 3
Data Set (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ascites (4939) 4939
humans (4611) 4611
animals (4224) 4224
female (3414) 3414
mice (2625) 2625
index medicus (2486) 2486
male (2164) 2164
oncology (2076) 2076
middle aged (1652) 1652
cancer (1526) 1526
aged (1267) 1267
adult (1208) 1208
tumors (1019) 1019
ascites tumor-cells (936) 936
research (931) 931
biochemistry & molecular biology (907) 907
ovarian cancer (895) 895
carcinoma (867) 867
rats (847) 847
ascites - etiology (785) 785
ascites - pathology (732) 732
carcinoma, ehrlich tumor (718) 718
ovarian neoplasms - pathology (693) 693
surgery (665) 665
cell biology (643) 643
expression (604) 604
chemotherapy (600) 600
cell line, tumor (599) 599
tumor cells, cultured (593) 593
pharmacology & pharmacy (569) 569
care and treatment (553) 553
prognosis (541) 541
analysis (526) 526
gastroenterology & hepatology (518) 518
malignant ascites (518) 518
apoptosis (514) 514
cells (512) 512
metastasis (511) 511
liver (503) 503
ascites - metabolism (495) 495
diagnosis (494) 494
ehrlich ascites tumor (458) 458
treatment outcome (452) 452
aged, 80 and over (451) 451
neoplasm transplantation (444) 444
neoplasms, experimental (437) 437
medicine & public health (435) 435
survival (402) 402
retrospective studies (401) 401
health aspects (398) 398
patients (394) 394
time factors (373) 373
antineoplastic agents - pharmacology (372) 372
proteins (368) 368
cirrhosis (365) 365
pathology (364) 364
neoplasms (352) 352
ovarian neoplasms - metabolism (345) 345
carcinoma, ehrlich tumor - drug therapy (344) 344
inhibition (334) 334
management (332) 332
diagnosis, differential (331) 331
obstetrics & gynecology (328) 328
carcinoma, ehrlich tumor - metabolism (322) 322
growth (322) 322
medicine, research & experimental (317) 317
liver cirrhosis (315) 315
carcinoma, ehrlich tumor - pathology (308) 308
immunology (306) 306
metabolism (306) 306
ehrlich ascites tumor cells (302) 302
ascites - drug therapy (298) 298
kinetics (296) 296
angiogenesis (293) 293
ehrlich ascites carcinoma (290) 290
medicine (284) 284
mice, inbred balb c (283) 283
cell line (282) 282
research article (276) 276
neoplasms - metabolism (274) 274
physiology (271) 271
radiology, nuclear medicine & medical imaging (268) 268
risk factors (268) 268
cells, cultured (265) 265
ovarian neoplasms - drug therapy (264) 264
multidisciplinary sciences (260) 260
immunohistochemistry (259) 259
gene expression (257) 257
tumor (255) 255
therapy (253) 253
activation (251) 251
antineoplastic agents - therapeutic use (251) 251
ascites - immunology (251) 251
ascites - diagnosis (247) 247
peritoneum (244) 244
dna (240) 240
in vitro techniques (239) 239
metastases (238) 238
cytotoxicity (237) 237
biophysics (235) 235
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10151) 10151
Japanese (354) 354
German (290) 290
Russian (105) 105
French (97) 97
Chinese (50) 50
Spanish (46) 46
Italian (45) 45
Korean (29) 29
Portuguese (13) 13
Czech (10) 10
Hungarian (9) 9
Polish (9) 9
Romanian (9) 9
Bulgarian (5) 5
Dutch (5) 5
Turkish (3) 3
Hebrew (2) 2
Persian (2) 2
Arabic (1) 1
Croatian (1) 1
Danish (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2010, Volume 107, Issue 17, pp. 7875 - 7880
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2012, Volume 8, Issue 1, pp. 71 - 80
Abstract The in vivo efficacy of doxorubicin (DOX)-loaded poly(γ-benzyl l -glutamate)- block -hyaluronan (PBLG23 - b -HYA10 )-based polymersomes (PolyDOX) was... 
Internal Medicine | Hyaluronan | Ehrlich ascites tumor (EAT) | Antitumor activity | Doxorubicin | Polymersomes | MEDICINE, RESEARCH & EXPERIMENTAL | BLOCK-COPOLYMERS | SOLID TUMORS | DRUG-DELIVERY | RECEPTOR | NANOSCIENCE & NANOTECHNOLOGY | VASCULAR-PERMEABILITY | CANCER | CARRIERS | PACLITAXEL | LIPOSOMAL DOXORUBICIN | ENDOCYTOSIS HARE | Doxorubicin - blood | Doxorubicin - therapeutic use | Drug Carriers - adverse effects | Hyaluronic Acid - therapeutic use | Nanoparticles - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Drug Carriers - administration & dosage | Polyglutamic Acid - administration & dosage | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Nanoparticles - adverse effects | Drug Carriers - chemistry | Polyglutamic Acid - analogs & derivatives | Antineoplastic Agents - adverse effects | Female | Hyaluronic Acid - blood | Hyaluronic Acid - adverse effects | Doxorubicin - administration & dosage | Endocytosis - immunology | Technetium - chemistry | Rabbits | Hyaluronic Acid - administration & dosage | Hyaluronic Acid - chemistry | Carcinoma, Ehrlich Tumor - drug therapy | Doxorubicin - chemical synthesis | Polyglutamic Acid - blood | Polyglutamic Acid - chemistry | Animals | Hyaluronic Acid - analogs & derivatives | Antineoplastic Agents - blood | Hyaluronan Receptors - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Polyglutamic Acid - therapeutic use | Neoplasms, Experimental - drug therapy | Doxorubicin - adverse effects | Polyglutamic Acid - adverse effects | Anthracyclines | Ascites | Hyaluronic acid | Tumors | Polymers | Chemical Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e84941
Cells with sphere forming capacity, spheroid cells, are present in the malignant ascites of patients with epithelial ovarian cancer (EOC) and represent a... 
INITIATING CELLS | PROGENITOR CELLS | CARCINOMA ASCITES SPHEROIDS | INVASION | PROSPECTIVE IDENTIFICATION | MULTIDISCIPLINARY SCIENCES | IN-VITRO MODEL | PROSTATE-CANCER | GROWTH | GENE-EXPRESSION | MASS ISOTOPOMER | Cell Proliferation | Neoplastic Stem Cells - drug effects | Humans | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Cell Movement - genetics | Hypoxia - metabolism | Ovarian Neoplasms - genetics | Neoplasm Metastasis | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Tumor Burden - genetics | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | Tumor Cells, Cultured | Spheroids, Cellular | Aldehyde Dehydrogenase - metabolism | Ovarian Neoplasms - drug therapy | Disease Models, Animal | Cell Transformation, Neoplastic - metabolism | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Cell Line, Tumor | Immunocompromised Host | Tumor Burden - immunology | Glucose metabolism | Chemotherapy | Stem cells | Development and progression | Transplantation | Metastasis | Drug resistance | Health aspects | Ovarian cancer | Cancer | Cell culture | Ovarian carcinoma | Stem cell transplantation | Oncology | Glucose | Aldehyde dehydrogenase | Metastases | Allografts | Immunology | Immunotherapy | Pentose | Surgery | Tumorigenesis | Growth factors | Tumor cells | Routing | Forming | Tumor cell lines | Metabolism | Gene expression | Spheroids | Glycolysis | Hypoxia | Ascites | Cell migration | Apoptosis | Tumors
Journal Article
Immunology, ISSN 0019-2805, 05/2018, Volume 154, Issue 1, pp. 132 - 143
Summary Exosomes derived from heat‐stressed tumour cells (HS‐TEXs), which contain abundant heat shock protein (HSP) 70, strongly induce antitumour immune... 
heat stress | Th17 | exosomes | Tregs | IL‐6 | IL-6 | ASCITES | CTL RESPONSE | VACCINE | EFFICIENT INDUCTION | IMMUNOLOGY | T-regs | LYMPHOCYTES | Exosomes - metabolism | T-Lymphocytes, Regulatory - metabolism | Adenocarcinoma - pathology | Cell Proliferation | Humans | Middle Aged | Tumor Microenvironment | Exosomes - pathology | Male | Colonic Neoplasms - metabolism | T-Lymphocytes, Regulatory - immunology | Adenocarcinoma - metabolism | Th17 Cells - metabolism | Time Factors | Colonic Neoplasms - immunology | Interleukin-6 - blood | Exosomes - immunology | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Cell Differentiation | Hyperthermia, Induced - methods | Interleukin-6 - metabolism | Colonic Neoplasms - therapy | Exosomes - transplantation | Signal Transduction | Adenocarcinoma - immunology | Mice, Inbred C57BL | Tumor Burden | Heat-Shock Response | Animals | Adenocarcinoma - therapy | Colonic Neoplasms - pathology | Interleukin-6 - immunology | Cell Line, Tumor | Th17 Cells - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Interleukins | Dendritic cells | Growth | Heat shock proteins | T cells | Cell differentiation | Tumors | Interleukin | Helper cells | Differentiation (biology) | Leukocytes (mononuclear) | Lymphocytes T | Exosomes | Anticancer properties | Lymphocytes | Peripheral blood mononuclear cells | Immune response | Transforming growth factor-b1 | Immunoregulation | Hsp70 protein | T cell receptors | Patients | Immunosuppression | Converting | Hyperthermia | Prostate | Neutralization | Heat shock | Original
Journal Article